Skip to main content
Tianjin Ringpu Bio-Technology Co.,Ltd. logo

Tianjin Ringpu Bio-Technology Co.,Ltd. — Investor Relations & Filings

Ticker · 300119 ISIN · CNE100000TV1 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 2,284 across all filing types
Latest filing 2026-03-30 Regulatory Filings
Country CN China
Listing Shenzhen Stock Exchange 300119

About Tianjin Ringpu Bio-Technology Co.,Ltd.

https://www.ringpu.com

Tianjin Ringpu Bio-Technology Co.,Ltd. is a high-tech enterprise specializing in the research, development, production, and sale of animal health products. The company offers a comprehensive portfolio that includes veterinary biological products, chemical drugs, feed additives, and pet health solutions. Its product range covers vaccines for poultry and livestock, as well as various pharmaceutical formulations such as injections, powders, and oral solutions. Ringpu Bio-Technology emphasizes innovation through its dedicated R&D centers, focusing on disease prevention and treatment to support the global animal husbandry industry. The company provides integrated health management services and high-quality veterinary medicines to ensure food safety and animal welfare.

Recent filings

Filing Released Lang Actions
2025年年度报告
Regulatory Filings
2026-03-30 Chinese
2025年度董事会工作报告
Management Reports Classification · 95% confidence The document is titled '2025 年度董事会工作报告' which translates to '2025 Annual Board of Directors Work Report'. It contains detailed information about the company's business operations, financial performance, strategic plans, board meeting summaries, committee reports, and management discussions for the year 2025. The content includes comprehensive analysis of business segments, R&D, marketing, governance, and future outlook. It is a detailed management report covering the company's activities and performance over the fiscal year. This matches the characteristics of a Management Reports (MDA) filing, which provides management's detailed explanation of financial results, business trends, and outlook. The document is not a full Annual Report (10-K) as it lacks full financial statements and audit opinions, nor is it a simple announcement or presentation. Therefore, the appropriate classification is MDA with high confidence.
2026-03-30 Chinese
独立董事2025年度述职报告（郭春林）
Board/Management Information Classification · 95% confidence The document is titled '独立董事 2025 年度述职报告' which translates to 'Independent Director 2025 Annual Work Report'. It is a detailed report by an independent director about their duties, attendance at meetings, communication with auditors, oversight of company governance, and other supervisory activities during the year 2025. The content focuses on the independent director's role, responsibilities, and evaluation of company governance and operations over the year. It is not an announcement or a brief summary but a substantive report on management oversight and governance activities. This fits the category of Board/Management Information (MANG), which includes announcements or reports related to changes or activities of the board or senior management. The document is not a full annual report (10-K), audit report (AR), or other financial report types, nor is it a regulatory filing or announcement. Therefore, the best classification is MANG with high confidence.
2026-03-30 Chinese
独立董事2025年度述职报告（王凯）
Board/Management Information Classification · 95% confidence The document is titled '独立董事 2025 年度述职报告' which translates to 'Independent Director 2025 Annual Work Report'. It is a detailed report by an independent director about their duties, attendance at meetings, communication with auditors, and overall evaluation of their role during the year 2025. The content focuses on governance, compliance with laws and regulations, and the director's activities and observations. It does not contain financial statements or audit results, nor is it an announcement or a brief summary. It is a management-related report focusing on board and governance activities, specifically the independent director's report on their duties and performance. This fits best under Board/Management Information (MANG) as it relates to board member activities and governance roles rather than a full annual report or audit report.
2026-03-30 Chinese
立信会计师事务所（特殊普通合伙）关于瑞普生物股份有限公司2025年度内部控制审计报告
Audit Report / Information Classification · 95% confidence The document is titled '内部控制审计报告' which translates to 'Internal Control Audit Report'. It references auditing standards and the responsibility of the board and auditors regarding internal control over financial reporting as of December 31, 2025. The document contains an auditor's opinion on the effectiveness of internal controls, signed by certified public accountants. It is a standalone audit report focused on internal control effectiveness, not a full annual report or financial statement. The document length is short (841 characters), but it contains substantive audit opinion content, not just an announcement. Therefore, it fits the category of Audit Report / Information (AR).
2026-03-30 Chinese
第六届董事会第三次会议决议公告
Board/Management Information Classification · 95% confidence The document is a detailed announcement of resolutions passed at the sixth board of directors meeting of 瑞普生物股份有限公司 on March 27, 2026. It includes approvals of various reports such as the 2025 Board Work Report, 2025 Audited Financial Report, 2025 Annual Report, 2025 ESG Report, profit distribution plan, and other corporate governance matters. The document repeatedly states that the detailed reports are disclosed separately on the Shenzhen Stock Exchange and CNINFO websites, indicating this document itself is not the full reports but a summary of board meeting decisions. It also mentions that many of these resolutions require approval at the 2025 Annual General Meeting (AGM). The document is a formal announcement of board meeting resolutions, not the actual annual report or financial statements. Therefore, it fits best into the category of Board/Management Information (MANG), as it announces board meeting decisions and management-related approvals.
2026-03-30 Chinese

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.